Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Psychotic”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Large-scale testing (Phase 3)Ended earlyNCT01908192
What this trial is testing

Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®

Who this might be right for
Schizophrenia
SyneuRx International (Taiwan) Corp 60
Early research (Phase 1)UnknownNCT02533232
What this trial is testing

Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Pakistan Institute of Living and Learning 60
Testing effectiveness (Phase 2)Study completedNCT03510741
What this trial is testing

Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizoaffective Disorder
Pakistan Institute of Living and Learning 64
Testing effectiveness (Phase 2)Looking for participantsNCT04917302
What this trial is testing

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia

Who this might be right for
Schizophrenia
China Medical University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00074477
What this trial is testing

Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 250
Testing effectiveness (Phase 2)Study completedNCT00029458
What this trial is testing

Clozapine for Treatment-Resistant Mania

Who this might be right for
Bipolar Disorder
National Institute of Mental Health (NIMH) 42
Not applicableUnknownNCT06238089
What this trial is testing

Anti-psychotic Drug Prescribing Patterns Within Specialist Adult ID Services in England and Wales

Who this might be right for
Intellectual Disability
University of Plymouth 600
Testing effectiveness (Phase 2)WithdrawnNCT01272752
What this trial is testing

Anti-psychotic Medication (New Use) Weight Loss Study

Who this might be right for
Obesity
Avera McKennan Hospital & University Health Center
Post-approval studies (Phase 4)UnknownNCT04020588
What this trial is testing

Anti-inflammatories and Adolescent Schizophrenia

Who this might be right for
Schizophrenia
Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico 90
Testing effectiveness (Phase 2)Study completedNCT02624167
What this trial is testing

Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia

Who this might be right for
Chronic Schizophrenia
Newron Pharmaceuticals SPA 90
Post-approval studies (Phase 4)Study completedNCT00334035
What this trial is testing

Antipsychotic Therapy and First Episode

Who this might be right for
Schizophrenia
The University of Hong Kong 169
Not applicableStudy completedNCT01793935
What this trial is testing

Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
K.N. Roy Chengappa 68
Early research (Phase 1)Study completedNCT00698022
What this trial is testing

A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers

Who this might be right for
Healthy
Corcept Therapeutics 76
Not applicableStudy completedNCT02449746
What this trial is testing

Study of Immunotherapy in Autoantibody Positive Psychosis

Who this might be right for
SchizophreniaPsychosisAuto Immune Disorders
University of Cambridge 10
Not applicableStudy completedNCT03183609
What this trial is testing

Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)

Who this might be right for
SchizophreniaGluten SensitivitySchizo Affective Disorder
University of Maryland, Baltimore 40
Large-scale testing (Phase 3)Study completedNCT00000179
What this trial is testing

Agitation in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
National Institute on Aging (NIA)
Not applicableNot Yet RecruitingNCT06563752
What this trial is testing

Exploring the Effectiveness of Digital Anti-stigma Therapy on Illness Perception and Perceived Stigma in Patients With Schizophrenia and Their Primary Caregivers

Who this might be right for
Schizophrenia
National Yang Ming Chiao Tung University 360
Testing effectiveness (Phase 2)Study completedNCT00483964
What this trial is testing

A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia

Who this might be right for
Schizophrenia
Q.Mundewadi Ayurvedic Research & Charitable Trust 200
Not applicableUnknownNCT03192631
What this trial is testing

Financial Incentives to Improve Acceptance of Antipsychotic Injections

Who this might be right for
SchizophreniaSchizo Affective DisorderBipolar I Disorder
Focus Community Mental Health Team 20
Testing effectiveness (Phase 2)Ended earlyNCT00686699
What this trial is testing

Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

Who this might be right for
Akathisia, Drug-InducedDyskinesia, Drug-InducedParkinsonian Disorders
Merck Sharp & Dohme LLC 11
Load More Results